Ticker
PALICompany Name
PALISADE BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 6.67M | $ 5.44M | 81.64% |
3/31/2025 | $ 8.19M | $ 7.26M | 88.6% |
12/31/2024 | $ 10.88M | $ 9.85M | 90.51% |
9/30/2024 | $ 9.34M | $ 8.07M | 86.4% |
6/30/2024 | $ 12.87M | $ 11.38M | 88.41% |
3/31/2024 | $ 12.65M | $ 11.3M | 89.33% |
12/31/2023 | $ 14.05M | $ 12.46M | 88.66% |
9/30/2023 | $ 17.07M | $ 15.34M | 89.87% |
6/30/2023 | $ 18.29M | $ 16.43M | 89.83% |
3/31/2023 | $ 15.26M | $ 13.32M | 87.3% |
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for PALISADE BIO INC is calculated as follows: CashnEq [ $ 12.65M ] / Assets [ $ 15.17M ]
(=) Cash to Assets [ 83.4% ]
Minimum
Jun 30, 2022
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.71% |
average | 9.76% |
median | 6.41% |
std | 9.51% |